Location

Heidelberg

München Tübingen Heidelberg Giessen – Marburg – Langen Bonn – Köln Hannover – Braunschweig Hamburg – Lübeck Borstel – Riems
Contact person

PD Dr. Dr. Angelika Riemer

German Cancer Research Center
Deputy Coordinator Infections of the immunocompromised Host
Deputy Partner Site Speaker Heidelberg
Group leader
Research areas

The research areas Hepatitis and Infections of the Immunocompromised Host are co-managed from Heidelberg. Furthermore, Heidelberg scientists coordinate the DZIF-wide Biobanking unit—since 2021 part of the DZIF infrastructure Bioresources, Biodata and Digital Health—with a focus on tissue banking. In addition to participating in the DZIF Clinical Trial Unit with a “First-In-Human (FIH)” unit for early clinical trials, Heidelberg researchers are working on combating malaria, developing antiviral therapy concepts for viral emerging infectious diseases, controlling HIV, as well healthcare-associated and antibiotic-resistant bacteria, and developing imaging methods to vizualise infections in systems of varying complexity.

Current news

Publications